A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to demonstrate the efficacy of the RSV F vaccine at a dose of 135µg via intramuscular (IM) injection in the prevention of moderate-severe RSV-associated lower respiratory tract disease (RSV-LRTD) in older adults ≥ 60 years of age.
Epistemonikos ID: e1aa10ab398b41b5b3c6703b2bf645d91f7f0c0b
First added on: Mar 23, 2020